Long-term reestablishment of alpha-L-iduronidase activity in MPS I fibroblasts after non-viral gene transfer
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder due to deficiency of alpha-L-iduronidase (IDUA). Limitations such as need of weekly injection, high morbidity and mortality and high cost of the current treatments show the need for new approaches to treat this disease. In this wo...
Main Authors: | Fabiano de Oliveira Poswar, Fabiana Quoos Mayer, Maira Graeff Burin, Ursula da Silveira Matte, Roberto Giugliani, Guilherme Baldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS)
2017-12-01
|
Series: | Clinical and Biomedical Research |
Subjects: | |
Online Access: | http://seer.ufrgs.br/index.php/hcpa/article/view/74048 |
Similar Items
-
Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
by: Ying Li, et al.
Published: (2022-04-01) -
Mucopolysaccharidosis Type I in Mexico: Case-Based Review
by: Consuelo Cantú-Reyna, et al.
Published: (2023-03-01) -
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
by: Christiane S. Hampe, et al.
Published: (2020-08-01) -
The Effects of Enzyme Replacement Therapy in Patients with Mucopolysaccharidosis Type 1: A Case Series Study
by: Peyman Eshraghi, et al.
Published: (2022-04-01) -
A Biochemical Platform to Define the Relative Specific Activity of <i>IDUA</i> Variants Identified by Newborn Screening
by: Seok-Ho Yu, et al.
Published: (2020-11-01)